GlassScriptPhysician profile
Ira B Fox
NPI 1598705592
$10,219.91
in general payments reported to CMS, 2019-2025
12 companies · $463 in 2025
The $463 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $126 · 2021: $349 · 2022: $4,836 · 2023: $1,774 · 2024: $2,087 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,323.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,348.47 | 2019-2023 | Proclaim, Eterna |
| Biotronik Nro, INC. | $2,876.62 | 2023-2025 | Prospera, Biotronik |
| Medtronic USA, INC. | $434.12 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $124.13 | 2022-2024 | Xtampza |
| Stimwave Technologies Incorporated | $115.92 | 2021 | |
| Boston Scientific Corporation | $81.06 | 2019-2022 | |
| Spr Therapeutics, INC | $78.00 | 2022 | |
| Medtronic, INC. | $72.56 | 2023 | Intellis Adaptivestim |
| Epimed International, INC | $41.50 | 2019 | |
| Abbvie INC. | $18.74 | 2023 | |
| Curonix LLC | $16.65 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Protega Pharmaceutials INC | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.